Case Study: Praxis Precision Medicines

Praxis Medicines is a clinical-stage biopharmaceutical company translating insights from genetic epilepsies into the development of therapies for central nervous systems (CNS) disorders characterized by neuronal excitation-inhibition imbalance. The needs of patients with CNS disorders are devastatingly urgent. The mission at Praxis is to help patients by delivering life-altering treatments faster and more effectively than has ever been done before - and to do it again and again.

We've brought their brand to the world and their purpose to life from steath mode to IPO and beyond.

To get in touch with Earls, email us @info@earls.co or contact us at earls.co.